Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

S1 Graphical - by Agnieszka Murawska (11021928)

Subjects:

Col outcomes QR. by Felipe Agudelo-Hernández (20790521)

“…</p><p>Results</p><p>Statistically significant improvements were observed in human rights understanding, reduced stigmatizing attitudes toward mental health and decreased authoritarianism. …”

Pre-post comparison of study variables. by Felipe Agudelo-Hernández (20790521)

“…</p><p>Results</p><p>Statistically significant improvements were observed in human rights understanding, reduced stigmatizing attitudes toward mental health and decreased authoritarianism. …”

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

<b>Data for s</b><b>easonal variations in coral lipids and their significance for energy maintenance in the </b><b>South China Sea</b> by Hongyan Mo (19721569)

“…The results show that ZD and the zooxanthellae photosynthesis intensity decreased in summer. Correspondingly,the content and δ13C of lipids are decreased significantly. …”

电针预处理通过心肌缺血损伤 棕色脂肪组织和 BMP3b/Smad1/5 通路小鼠 by Danying Qian (21730250)

Subjects: “…electroacupuncture significantly decreased…”

Box plots showing the taxa that were significantly different between thin and normal cows. by Bhuripit Saraphol (20855573)

Subjects:

Primer sequences used for RT-PCR. by Jingjing Chen (293564)

“…Notably, SIRT1 levels decrease with age in both mice and during cellular senescence, highlighting its significance in anti-aging processes. …”

Antibody reagent list. by Helena Saura Martinez (22305113)

“…In <i><i>T. bryosalmonae</i></i> exposed animals, parasite concentration increased significantly over time. Moreover, a proportional increase in IgM⁺ B cells and a proportional decrease in myeloid cells over time was observed. …”

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

“…Areas of all BrdU + /Hu+ neurons measured in control birds (dark orange line) and statin-treated birds (light orange line) shows qualitatively that statins did not decrease soma sizes of small cells (overlap of orange lines), and statins did not curtail the upper limit of soma size (light orange line reaches a soma size of > 200 µm, Y axis, top panel). …”

ELISA analysis revealed a significant decrease in SP (A & B) and CGRP (C & D) protein levels in the corneas and tear fluid of mice treated with 0.5% bupivacaine (BUP) every alternate day for 15 days (administered via subconjunctival injection (SCI) alone or in combination with topical (TOP) application) compared to PBS-treated controls. by Ananya Datta (19932144)

Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

“…Singers produced significantly smaller mean smallest changes of both <i>F</i>0 and intensity than nonsingers.…”

The (A) logistic regression model (LRM) and (B) random forest model (RFM) with only conservation scores as independent variables (orange, yellow) show decreased model fitting metri... by Bushra Haque (20513785)

Data Sheet 1_Previous COVID-19 infection significantly reduces elastase levels in newly diagnosed pulmonary tuberculosis patients.pdf by Nancy Hilda Joseph (21837314)

“…Introduction<p>Tuberculosis (TB) is considered a risk factor for severe COVID-19 disease and the quality of life of patients co-infected with COVID-19 and TB is significantly impacted due to the nature of these diseases. …”